Resurfacing an August move: Marico Q1 FY26 revenue rose 23% as India business grew 27%; profit up 8%
Marico had reported Q1 FY26 revenue from operations of Rs 3,259 crore, up 23.3% year on year, with India revenue growing 27.2% to Rs 2,495 crore. Consolidated net profit rose 8.2% to Rs 513 crore. The company also lifted its stake in Plix maker Satiya Nutraceuticals to 60% on a fully diluted basis.
What happened
Marico reported strong Q1 FY26 growth, led by a 27.17% increase in India revenue and 8.2% profit growth. It expects sustained volume and revenue momentum
Key facts
- Q1 FY26 consolidated net profit rose 8.2% YoY to Rs 513 crore from Rs 474 crore
- Revenue from operations rose 23.31% to Rs 3,259 crore from Rs 2,643 crore
- Total income was Rs 3,315 crore, including Rs 56 crore other income
- Total expenses rose to Rs 2,659 crore from Rs 2,075 crore
- India revenue grew 27.17% to Rs 2,495 crore from Rs 1,962 crore
- International revenue grew 12.91% to Rs 764 crore from Rs 681 crore
- India segment PBT was Rs 469 crore
- International segment PBT was Rs 213 crore
- Marico increased its stake in Satiya Nutraceuticals to 60% on a fully diluted basis
Why this matters
Increasing the Plix stake to 60% deepens Marico’s exposure to fast-growing wellness and nutrition, reinforcing its portfolio shift beyond core FMCG.
What to watch
- Sequential India volume growth versus price-led growth in the next quarterly update.
- Gross-margin and EBITDA-margin movement, particularly relative to revenue growth.
- Copra, edible oil, crude-linked packaging and freight cost trends.
- Advertising and sales-promotion expense growth as a percentage of revenue.
- Plix revenue growth, offline retail expansion, new product cadence and evidence of post-acquisition profitability.
- Market-share trends in coconut oil, value-added hair oils, foods and wellness categories.
- Management commentary on pricing actions, rural demand, urban discretionary consumption and FY26 margin guidance.
- Increase distribution and marketing support behind faster-growing India categories, especially foods, premium personal care, health and nutrition.
- Integrate Plix/Satiya Nutraceuticals more closely through retail distribution expansion, product launches, supply-chain leverage and omnichannel cross-selling.
- Use calibrated price increases, grammage adjustments and premium SKU mix to protect margins if copra, edible oil or packaging costs remain elevated.
- Maintain elevated advertising and promotional spending to defend share against FMCG incumbents and digital-native wellness brands.
- Seek international growth diversification while keeping India as the primary growth and investment engine.